Blood

Vol. 145, Issue 10 Issue 10 2025
16
Articles

Articles in this Issue

Cullin-5 controls the number of megakaryocyte-committed stem cells to prevent thrombocytosis in mice

Maria Kauppi, Craig D. Hyland, Elizabeth M. Viney et al. Mar 06, 2025 pp. 1034-1046 10.1182/blood.2024025406

Abstract Cullin-5 (Cul5) coordinates the assembly of cullin-RING-E3 ubiquitin ligase complexes that include the suppressors of cytokine signaling (SOCS)-box–containing proteins. The...

Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia

Peihua Lu, Xian Zhang, Junfang Yang et al. Mar 06, 2025 pp. 1022-1033 10.1182/blood.2024024861

Abstract Approximately 30% of patients with acute myeloid leukemia (AML) express CD7 on their myeloblasts. We have previously demonstrated that single-chain variable fragment (scFv)–...

Prolymphocytic progression of splenic marginal zone lymphoma

Concepción Prats-Martín, Rosario M. Morales-Camacho Mar 06, 2025 pp. 1097-1097 10.1182/blood.2024027259

Therapy for MYD88 L265P DLBCL

Joost S. P. Vermaat, Ruben A. L. de Groen Mar 06, 2025 pp. 998-1000 10.1182/blood.2024027538

Air pollution is associated with increased risk of venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis

Pamela L. Lutsey, Jeffrey R. Misialek, Michael T. Young et al. Mar 06, 2025 pp. 1089-1096 10.1182/blood.2024026399

Abstract Air pollution exposure may induce procoagulant effects, and chronic exposure may be linked to greater risk of venous thromboembolism (VTE). We tested the hypothesis that air...

Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation

Wei Li, Ruirui Wang, Junhao Wang et al. Mar 06, 2025 pp. 1047-1060 10.1182/blood.2024026781

Abstract Myeloid differentiation primary response protein 88 (MYD88) is a key adaptor molecule in the signaling pathways of toll-like receptor and interleukin-1 receptor. A somatic m...

Mutations in <i>AMBRA1</i> aggravate β-thalassemia by impairing autophagy-mediated clearance of free α-globin

Yong Long, Qianqian Zhang, Ling Ling et al. Mar 06, 2025 pp. 1074-1088 10.1182/blood.2023022688

Abstract Accumulation of free α-globin is a critical factor in the pathogenesis of β-thalassemia. Autophagy plays a crucial role in clearing toxic free α-globin, thereby reducing dis...

Childhood Langerhans cell histiocytosis hematological involvement: severity associated with <i>BRAF</i> <i>V600E</i> loads

Julian Thalhammer, Éric Jeziorski, Perrine Marec-Bérard et al. Mar 06, 2025 pp. 1061-1073 10.1182/blood.2024025625

Abstract Hematological involvement (HI) is one of the life-threatening risk organs (ROs) in Langerhans cell histiocytosis (LCH). Lahey criteria have defined HI since 1975 as hemoglob...

Over 4 decades, French children teach about LCH

Barbara A. Degar, Barrett J. Rollins Mar 06, 2025 pp. 1000-1001 10.1182/blood.2024027160

The contribution of the monocyte-macrophage lineage to immunotherapy outcomes

Rachael C. Adams, Kelli P. A. MacDonald, Geoffrey R. Hill Mar 06, 2025 pp. 1010-1021 10.1182/blood.2024025680

Abstract Macrophages execute core functions in maintaining tissue homeostasis, in which their extensive plasticity permits a spectrum of functions from tissue remodeling to immune de...

ALK+ anaplastic large cell lymphoma expressing CD33 and myeloid nuclear differentiation antigen

Miguel Gonzalez Mancera, Oscar Silva Mar 06, 2025 pp. 1098-1098 10.1182/blood.2024027618

Cullin’ the herd: Cul5 limits megakaryocyte-biased HSCs

Eric M. Pietras Mar 06, 2025 pp. 996-998 10.1182/blood.2024027680

Air pollution and venous thromboembolism

Ingrid Pabinger, Cihan Ay Mar 06, 2025 pp. 1003-1004 10.1182/blood.2024027502

CD7 CAR-T: a bridge to transplant in AML

Maksim Mamonkin Mar 06, 2025 pp. 995-996 10.1182/blood.2024027442

AMBRA1 performs a balancing act in β-thalassemia

Christophe Lechauve, Mitchell J. Weiss Mar 06, 2025 pp. 1001-1003 10.1182/blood.2024027597

Novel mechanisms of resistance in CLL: variant BTK mutations in second-generation and noncovalent BTK inhibitors

Constantine S. Tam, Shalini Balendran, Piers Blombery Mar 06, 2025 pp. 1005-1009 10.1182/blood.2024026672

Abstract Bruton tyrosine kinase inhibitors (BTKis) are an established standard of care in chronic lymphocytic leukemia. The covalent BTKis ibrutinib, acalabrutinib, and zanubrutinib...

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page